相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury
Satoshi Nakao et al.
ANNALS OF THORACIC SURGERY (2022)
Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis
Kazuki Tanaka et al.
RESPIRATORY INVESTIGATION (2021)
Ozone exposure promotes pyroptosis in rat lungs via the TLR2/4-NF-κB-NLRP3 signaling pathway
Lei Tian et al.
TOXICOLOGY (2021)
Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients
Kakuhiro Yamaguchi et al.
SCIENTIFIC REPORTS (2021)
Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer
Atsushi Kagimoto et al.
BMC PULMONARY MEDICINE (2021)
Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis
Kakuhiro Yamaguchi et al.
RESPIROLOGY (2020)
Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis
Norimichi Akiyama et al.
RESPIROLOGY (2020)
Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer
Miya Haruna et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2020)
The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients
Takumi Kinjo et al.
SCIENTIFIC REPORTS (2020)
The S100 calcium-binding protein A4 level is elevated in the lungs of patients with idiopathic pulmonary fibrosis
Jong-Uk Lee et al.
RESPIRATORY MEDICINE (2020)
Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
Satoshi Nakao et al.
RESPIRATORY MEDICINE (2020)
Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
Kakuhiro Yamaguchi et al.
RESPIRATORY RESEARCH (2020)
Acute exacerbation of interstitial lung disease after procedures
William H. Amundson et al.
RESPIRATORY MEDICINE (2019)
Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin
Takashi Kida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury
Seonyeong Lee et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
HMGB1 contributes to the irradiation-induced endothelial barrier injury through receptor for advanced glycation endproducts (RAGE)
Haihong Zhou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Association of serum high-mobility group box protein 1 level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
Hiroshige Shimizu et al.
PLOS ONE (2018)
Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections
Mira C. Patel et al.
MBIO (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
S100A4+ Macrophages Are Necessary for Pulmonary Fibrosis by Activating Lung Fibroblasts
Yanan Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
Carlos Machahua et al.
RESPIRATORY RESEARCH (2018)
Anticancer drug treatment for advanced lung cancer with interstitial lung disease
Kohei Otsubo et al.
RESPIRATORY INVESTIGATION (2018)
Nintedanib in Japanese patients with idiopathic pulmonary fibrosis: A subgroup analysis of the INPULSIS® randomized trials
Arata Azuma et al.
RESPIROLOGY (2017)
HMGB1 induces lung fibroblast to myofibroblast differentiation through NF-κB-mediated TGF-β1 release
Qiong Wang et al.
MOLECULAR MEDICINE REPORTS (2017)
Receptor for advanced glycation endproducts (RAGE) maintains pulmonary structure and regulates the response to cigarette smoke
Lisa Wolf et al.
PLOS ONE (2017)
AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis
Kakuhiro Yamaguchi et al.
RESPIROLOGY (2017)
RAGE inhibition reduces acute lung injury in mice
Raiko Blondonnet et al.
SCIENTIFIC REPORTS (2017)
Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
Ani Manichaikul et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)
Acute exacerbation in interstitial Lung Disease
Gabriela Leuschner et al.
FRONTIERS IN MEDICINE (2017)
Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report
Harold R. Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury
Yasuhisa Izushi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Respiratory Syncytial Virus Infection Triggers Epithelial HMGB1 Release as a Damage-Associated Molecular Pattern Promoting a Monocytic Inflammatory Response
Yashoda M. Hosakote et al.
JOURNAL OF VIROLOGY (2016)
Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis
Carlos Machahua et al.
RESPIRATORY RESEARCH (2016)
Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice
P. Gopal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
High-mobility group box 1 accelerates lipopolysaccharide-induced lung fibroblast proliferation in vitro: involvement of the NF-κB signaling pathway
Wen Li et al.
LABORATORY INVESTIGATION (2015)
Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway
Xian Jin et al.
BIOMED RESEARCH INTERNATIONAL (2015)
High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling
Liu-Cheng Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic Differences
Motoki Natsuizaka et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer
Toshihiko Sato et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis
Keishi Oda et al.
RESPIRATORY RESEARCH (2014)
Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease
Donavan T. Cheng et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-kappa B pathway
Xiaojin Wu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis
Thomas J. Richards et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis
Atsuko Hara et al.
RESPIRATORY MEDICINE (2012)
Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells
Naoko Yamakawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Sharon Chao Wootton et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Reduction in Serum High Mobility Group Box-1 Level by Polymyxin B-Immobilized Fiber Column in Patients with Idiopathic Pulmonary Fibrosis with Acute Exacerbation
Shinji Abe et al.
BLOOD PURIFICATION (2011)
Calgranulin B (S100A9/MRP14): A Key Molecule in Idiopathic Pulmonary Fibrosis?
Elena Bargagli et al.
INFLAMMATION (2011)
The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer
Hirotsugu Kenmotsu et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice
Frank Silva Bezerra et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2011)
Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Masahito Ebina et al.
PULMONARY MEDICINE (2011)
Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway
Akiko Hirose et al.
FEBS LETTERS (2010)
The Receptor for Advanced Glycation End Products (RAGE) and the Lung
Stephen T. Buckley et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer
R. Jing et al.
NEOPLASMA (2010)
Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
Steffen Ohlmeier et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Kazuhisa Konishi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
RAGE signaling in inflammation and arterial aging
Li Lin et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Association of Polymorphism in the Receptor for Advanced Glycation End Products (RAGE) Gene with Circulating RAGE Levels
Katrien H. J. Gaens et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer
Guan-Hong Shang et al.
RESPIRATORY MEDICINE (2009)
Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis
E. Bargagli et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2009)
Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats
Lei Chen et al.
RESPIRATORY RESEARCH (2009)
A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis
Judson M. Englert et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The role of high mobility group box1 in pulmonary fibrosis
Naoki Hamada et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications
Giuseppina Basta
ATHEROSCLEROSIS (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
Ling Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
HMGB1: Endogenous danger signaling
John R. Klune et al.
MOLECULAR MEDICINE (2008)
Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia
Marieke A. D. van Zoelen et al.
SHOCK (2008)
The role of the receptor for advanced glycation end-products in lung fibrosis
Mei He et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
C-reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells
Yun Zhong et al.
HYPERTENSION (2006)
Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury
Eileen N. Ogawa et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Potential role of high mobility group box 1 in viral infectious diseases
HC Wang et al.
VIRAL IMMUNOLOGY (2006)
Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells
N Demling et al.
CELL AND TISSUE RESEARCH (2006)
High-mobility group box 1 (HMGB1) protein: Friend and foe
Luis Ulloa et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
HMGB1 contributes to the development of acute lung injury after hemorrhage
JY Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Amphoterin as an extracellular regulator of cell motility: from discovery to disease
HJ Huttunen et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Identification of genes differentially expressed in rat alveolar type I cells
K Dahlin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Contributions of high mobility group box protein in experimental and clinical acute lung injury
H Ueno et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells
C Fiuza et al.
BLOOD (2003)
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
H Yonekura et al.
BIOCHEMICAL JOURNAL (2003)
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response
MA Hofmann et al.
GENES AND IMMUNITY (2002)
分享论文
